Karunatilake Chulani bought HOWL

January 2, 2024 · Form 4 insider transaction

Karunatilake Chulani bought 150,000 shares of Werewolf Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
150,000
Price
$0.00
Total value
N/A
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2024
Filing dateJanuary 4, 2024
Shares owned after150,000
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The option was granted on January 2, 2024 with a Vesting Commencement Date of January 1, 2024. The shares underlying the option vest in equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2028.

View the original Form 4 on SEC EDGAR